Archivos suplementarios
Palabras clave
Adultos
GINA
Cómo citar
Plaudit
Resumen
Antecedentes: Estudios en niños han identificado factores asociados con la falta de control del asma. En adultos no están bien definidos.
Objetivo: Identificar los factores relacionados con la falta de control del asma en adultos.
Métodos: Se incluyeron adultos con asma clasificados como controlados, parcialmente controlados y no controlados según los criterios de la Global Initiative for Asthma.
Resultados: Se incluyeron 200 pacientes (75.5 % mujeres), edad promedio de 38.4 ± 11.93 años. Cien pacientes con asma controlada y 100 con asma no controlada y parcialmente controlada; 35 (88.2 %) con persistencia leve, 14 (10 %) con persistencia moderada y 97 (1.8 %) con persistencia grave; en estrés se encontró RM = 0.41 (IC 95 % = 0.23-0.75), p = 0.03; en tabaquismo actual y activo, RM = 4.23 (IC 95 % = 1.35-13.2), p = 0.007; y en uso correcto de inhaladores, RM = 0.36 (IC 95 % = 0.13-0.97), p = 0.031. Los pacientes no tuvieron contacto con peluches ni alfombras.
Conclusiones: Se observó asociación con tabaquismo actual activo y dermatitis atópica. Como factores de protección se identificó niveles normales de eosinófilos en sangre, uso correcto de inhaladores, VEF1 > 80 %, ausencia de estrés y de contacto con alfombras y peluches.
Referencias
Prosser R, Carleton B, Smith A. The comorbidity burden of the treated asthma patient population in British Columbia. Chronic Dis Can. 2010;30(2):46-55. Disponible en: https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-30-no-2-2010/comorbidity-burden-treated-asthma-patient-population-british-columbia.html
Platts-Mills TA, Erwin EA, Heymann PW, Woodfolk JA. Pro: the evidence for a causal role of dust mites in asthma. Am J Respir Crit Care Med. 2009;180(2):109-121. DOI: 10.1164/rccm.200811-1756PR
Tovey E, Ferro A. Time for new methods for avoidance of house dust mite and other allergens. Curr Allergy Asthma Rep. 2012;12(5):465-477. DOI: 10.1007/s11882-012-0285-0
Gershon AS, Wang C, Guan J, To T. Burden of comorbidity in individuals with asthma. Thorax. 2010;65(7):612-618. DOI: 10.1136/thx.2009.131078
Global Strategy for Asthma Management and Prevention. EE. UU.: Global Initiative for Asthma (GINA); 2018. Disponible en: https://ginasthma.org/wp-content/uploads/2018/04/wms-GINA-2018-report-V1.3-002.pdf
National Asthma Education and Prevention Program. Expert Panel Report 3. Guidelines for the diagnosis and management of asthma. EE. UU.: Department of Health and Human Services/National Institutes of Health/National Heart, Lung, and Blood Institute; 2007. Disponible en: https://www.nhlbi.nih.gov/files/docs/guidelines/asthgdln.pdf
British Thoracic Society/Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. Escocia: British Thoracic Society/Scottish Intercollegiate Guidelines Network; 2008. Disponible en: https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthma-guideline-2008/
Cazzola M, Calzetta L, Bettoncelli G, Novelli L, Cricelli C, Rogliani P, et al. Asthma and comorbid medical illness. Eur Respir J. 2011;38(1):42-49. DOI: 10.1183/09031936.00140310
Antunes J, Fernandes A, Miguel-Borrego L, Leiria-Pinto P, Cavaco J. Cystic fibrosis, atopy, asthma and ABPA. Allergol Immunopathol (Madr). 2010;38(5):278-284. DOI: 10.1016/j.aller.2010.06.002
Vandenplas O, Dramaix M, Joos G, Louis R, Michils A, Verleden G, et al. The impact of concomitant rhinitis on asthma-related quality of life and asthma control. Allergy. 2010;65(10):1290-1297. DOI: 10.1111/j.1398-9995.2010.02365.x
Thilsing T, Rasmussen J, Lange B, Kjeldsen AD, Al-Kalemji A, Baelum J. Chronic rhinosinusitis and occupational risk factors among 20- to 75-year-old Danes: a GA2LEN-based study. Am J Ind Med. 2012;55(11):1037-1043. DOI: 10.1002/ajim.22074
Jarvis D, Newson R, Lotvall J, Hastan D, Tomassen P, Keil T, et al. Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy. 2012;67(1):91-98. DOI: 10.1111/j.1398-9995.2011.02709.x
Franco-Marina F, Fernández-Plata R, Torre-Bouscoulet L, García-Sancho C, Sánchez-Gallen E, Martínez D, Pérez-Padilla R. Efficient screening for COPD using three steps: a cross-sectional study in Mexico City. NPJ Prim Care Respir Med. 2014;24:14002. DOI: 10.1038/npjpcrm.2014.2
Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2010;(8):CD001186. DOI: 10.1002/14651858.CD001186.pub2
Chipps BE, Zeiger RS, Borish L, Wenzel SE, Yegin A, Hayden ML, et al. Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol. 2012;130(2):332-342. DOI: 10.1016/j.jaci.2012.04.014
Harris M, Lundien M, Finnie D, Williams A, Beebe T, Sloan J, et al. Application of a novel socioeconomic measure using individual housing data in asthma research: an exploratory study. NPJ Prim Care Respir Med. 2014;24:14018. DOI: 10.1038/npjpcrm.2014.18
Halimi L, Pry R, Pithon G, Godard P, Varrin M, Chanez P. Severe asthma and adherence to peak flow monitoring: longitudinal assessment of psychological aspects. J Psychosom Res. 2010;69(4):331-340. DOI: 10.1016/j.jpsychores.2010.02.007
Just J, Gouvis-Echraghi R, Couderc R, Guillemot-Lambert N, Saint-Pierre P. Novel severe wheezy young children phenotypes: boys atopic multiple-trigger and girls nonatopic uncontrolled wheeze. J Allergy Clin Immunol. 2012;130(1):103-110. DOI: 10.1016/j.jaci.2012.02.041
Sánchez J, Diez S, Cardona R. Frequency of sensitization to animals in a tropical area. Rev Alerg Mex. 2014;61(2):81-89. DOI: 10.29262/ram.v61i2.30
Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466-476. DOI: 10.1016/j.jaci.2010.06.047
Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J. 2014;44(2):304-323. DOI: 10.1183/09031936.00014614
Portelli MA, Hodge E, Sayers I. Genetic risk factors for the development of allergic disease identified by genome wide association. Clin Exp Allergy. 2014;45(1):21-31. DOI: 10.1111/cea.12327
Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218-224. DOI: 10.1164/rccm.200711-1754OC
Amelink M, De Nijs SB, Berger M, Weersink EJ, Ten-Brinke A, Sterk PJ, et al. Nonatopic males with adult onset asthma are at risk of persistent airflow limitation. Clin Exp Allergy. 2012;42(5):769-774. DOI: 10.1111/j.1365-2222.2012.03977.x
Reponen T, Levin L, Zheng S, Vesper S, Ryan P, Grinshpun SA, LeMasters G. Family and home characteristics correlate with mold in homes. Environ Res. 2013;124:67-70. DOI: 10.1016/j.envres.2013.04.003
Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, et al. Guidelines of care for the management of atopic dermatitis: section 1. diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-351. DOI: 10.1016/j.jaad.2013.10.010
Lai CK, Beasley R, Crane J, Foliaki S, Shah J, Weiland S, et al. Thorax. 2009;64(6):476-483. DOI: 10.1136/thx.2008.106609
Koh YY, Kim CK. Desarrollo de asma en pacientes con rinitis alérgica. Curr Opin Allergy Clin Immunol. 2003;3(3):159-164.
Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59-99. DOI: 10.1164/rccm.200801-060ST
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Derechos de autor 2019 Revista Alergia México